DAFNA Capital trims iShares Biotechnology ETF within broader biotech portfolio, according to recent SEC filing

DAFNA Capital trims iShares Biotechnology ETF within broader biotech portfolio, according to recent SEC filing

According to a February 17, 2026 SEC filing, DAFNA Capital Management LLC reduced its stake in iShares Biotech ETF (NASDAQ:IBB) for 34,405 shares during the fourth quarter of 2025. The value of the fund’s quarter-end IBB position decreased by $3.31 million, a figure that took into account both share sales and price movement. Following the…

Read More